|
Patient underwent primary thr where a competitor femoral component and a competitor acetabular component was utilised (dr.(b)(6), date unknown).Patient presented with pain and the components were removed and a temporary "kiwi" spacer implanted - competitor stem and cup (dr.(b)(6), date unknown) patient was returned for the second of the two stage procedure where a competitor acetabular shell with dual mobility and an srom stem was utilised ((b)(6) 2022).Patient has presented with ongoing pain and a decision was made to perform a washout with liner exchange and a head exchange ((b)(6) 2022).No obvious signs of infection were evident.Unsure whether any organisms have been cultured.Did the patient experience a post-op device malfunction? unknown, if yes, please describe.Possible infection - but this suspected at time of s rom stem implantation as this was the second of a two stage procedure, did the patient experience an adverse event such as infection, non-union, allergic reaction, osteoporosis, overloading, pain, degenerative diseases, bleeding or oozing? unknown, did the patient require revision surgery or hardware removal? yes, facility name of original implant: (b)(6) hospital, was device explanted? true, hardware/explant removal due to: washout and head/ liner exchange, did patient require revision surgery? true, if yes, date of revision surgery.(b)(6) 2022, reason for revision surgery.Infection suspected - washout, patient status/ outcome/ consequences, patient consequence description/was there a clinical outcome experienced by the patient (infection, inflammation, etc.)? possible/ suspected infection, was other medical intervention (e.G.X-rays, additional procedures, prescriptions, otc, revision) required: unknown, is the patient part of a clinical study? unknown, (b)(6).Device property of? none, device in possession of? none, (b)(6).Device property of? none, device in possession of? none, (b)(6).Device property of? none, device in possession of? none.By checking this box i certify that all information that are known/available has been disclosed.If any new information will be made available, the additional information will be submitted through cst.True.
|
|
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: if information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Corrected: e4.
|